MedPath
HSA Approval

SUNTUSS SYRUP

SIN03491P

SUNTUSS SYRUP

SUNTUSS SYRUP

June 24, 1989

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R05FB02

cough suppressants and expectorants

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL SDN BHD

Active Ingredients

AMMONIUM CHLORIDE

125 mg/5 ml

Ammonium chloride

DIPHENHYDRAMINE HCl

10 mg/5 ml

Diphenhydramine

DEXTROMETHORPHAN HBr

5 mg/5 ml

Dextromethorphan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SUNTUSS SYRUP - HSA Approval | MedPath